Related Experiment Videos
Dexamethasone suppression test in positive and negative schizophrenia
C Altamura1, G Guercetti, M Percudani
1Institute of Clinical Psychiatry, University of Milan, Italy.
Psychiatry Research
|October 1, 1989
Summary
Schizophrenia patients show elevated cortisol levels, with many failing the dexamethasone suppression test. Negative subtype schizophrenia patients were more likely to be nonsuppressors, indicating potential hypothalamic-pituitary-adrenal axis dysregulation.
Area of Science:
- Neuroscience
- Psychiatry
- Endocrinology
Background:
- Schizophrenia is a complex psychiatric disorder.
- The hypothalamic-pituitary-adrenal (HPA) axis is implicated in stress response and psychiatric conditions.
- Previous research suggests HPA axis dysregulation in schizophrenia.
Purpose of the Study:
- To investigate plasma cortisol levels and dexamethasone suppression test (DST) response in schizophrenic patients.
- To compare DST results between positive and negative subtypes of schizophrenia.
Main Methods:
- Fifty-four inpatients diagnosed with schizophrenia were recruited.
- Plasma cortisol levels were measured over two days.
- A single 1 mg oral dose of dexamethasone was administered at 11 p.m.
- Dexamethasone suppression test (DST) was performed to assess cortisol suppression.
Main Results:
- Schizophrenic patients exhibited significantly increased plasma cortisol levels.
- 40% of all studied patients were nonsuppressors on the DST.
- A higher proportion (62.5%) of patients with negative subtype schizophrenia were nonsuppressors compared to other subtypes.
Conclusions:
- The findings suggest HPA axis dysregulation in schizophrenia.
- Negative subtype schizophrenia may be associated with more pronounced HPA axis dysfunction.
- DST may serve as a biomarker for specific schizophrenia subtypes.